Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T23:02:58.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing visible content with an access-denied message and preventing access to the study details.
    Difference
    20%
    Check dated 2026-09-22T23:40:33.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6 label, reflecting a software version update.
    Difference
    0.0%
    Check dated 2026-09-16T00:07:03.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now shows a new revision label v3.6.6, replacing v3.6.5, indicating a minor update to the page's revision history. No substantive changes to the study details are described.
    Difference
    0.0%
    Check dated 2026-09-01T18:41:01.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.4 to v3.6.5, signaling a new deployment/version of the page. This appears to be an administrative update and does not alter the study data or visible content.
    Difference
    0.0%
    Check dated 2026-08-11T17:59:04.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page shows a new revision number, signaling a backend or UI update to the page. No study details or results are altered.
    Difference
    0.0%
    Check dated 2026-07-28T14:40:22.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.